Standardization of lower extremity quantitative lymphedema measurements and associated patient-reported outcomes in gynecologic cancers.

Journal Article (Journal Article;Review)

Practice changing standardization of lower extremity lymphedema quantitative measurements with integrated patient reported outcomes will likely refine and redefine the optimal risk-reduction strategies to diminish the devastating limb-related dysfunction and morbidity associated with treatment of gynecologic cancers. The National Cancer Institute (NCI), Division of Cancer Prevention brought together a diverse group of cancer treatment, therapy and patient reported outcomes experts to discuss the current state-of-the-science in lymphedema evaluation with the potential goal of incorporating new strategies for optimal evaluation of lymphedema in future developing gynecologic clinical trials.

Full Text

Duke Authors

Cited Authors

  • Russo, S; Walker, JL; Carlson, JW; Carter, J; Ward, LC; Covens, A; Tanner, EJ; Armer, JM; Ridner, S; Hayes, S; Taghian, AG; Brunelle, C; Lopez-Acevedo, M; Davidson, BA; Schaverien, MV; Ghamande, SA; Bernas, M; Cheville, AL; Yost, KJ; Schmitz, K; Coyle, B; Zucker, J; Enserro, D; Pugh, S; Paskett, ED; Ford, L; McCaskill-Stevens, W

Published Date

  • February 2021

Published In

Volume / Issue

  • 160 / 2

Start / End Page

  • 625 - 632

PubMed ID

  • 33158510

Pubmed Central ID

  • PMC7946397

Electronic International Standard Serial Number (EISSN)

  • 1095-6859

Digital Object Identifier (DOI)

  • 10.1016/j.ygyno.2020.10.026


  • eng

Conference Location

  • United States